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Background: A medical tests may influence the health of patients by guiding clinical decisions, such as treatment
in case of a positive test result. However, a medical test can influence the health of patients through other
mechanisms as well, like giving reassurance. To make a clinical recommendation about a medical test, we should
be aware of the full range of effects of that test on patients. This requires an understanding of the range of effects
that medical testing can have on patients. This study evaluates the mechanisms through which medical testing can
influence patients’ health, other than the effect on clinical management, from a gynecologist’s perspective.
Methods: A qualitative study in which explorative focus groups were conducted with gynecologists, gynecological
residents and gynecological M.D. researchers (n = 43). Discussions were transcribed verbatim. Transcriptions were
coded inductively and analyzed by three researchers.
Results: All participants contributed various clinical examples in which medical testing had influenced patients’
health. Clinical examples illustrated that testing, in itself or in interaction with contextual factors, may provoke a
wide range of effects on patients. Our data showed that testing can influence the doctor’s perceptions of the
patients’ appraisal of their illness, their perceived control, or the doctor-patient relationship. This may lead to
changes in psychological, behavioral, and/or medical outcomes, both favorably or unfavorably. The data were used
to construct a conceptual framework of effects of medical testing on patients.
Conclusions: Besides supporting clinical decision making, medical testing may have favorable or unfavorable
effects on patients’ health though several mechanisms.
Keywords: Test evaluation, Patient outcomes, Diagnostic test, Methodology, Qualitative researchBackground
Medical therapies are often systematically evaluated for
their clinical effects before they become common prac-
tice. On the other hand, medical tests are frequently
implemented without a thorough evaluation of their
actual influence on patients’ health. If medical tests or
biomarkers are evaluated, it is most common to measure
their ability to identify patients with the target disease or
condition in terms of sensitivity and specificity. Yet, to* Correspondence: jolandevis@gmail.com
1Department of Obstetrics and Gynecology, Academic Medical Center,
Amsterdam, The Netherlands
3Department of Clinical Epidemiology, Biostatistics and Bioinformatics,
Academic Medical Center, Amsterdam, The Netherlands
Full list of author information is available at the end of the article
© 2013 Vis et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormake an evidenced based decision whether to include a
medical test in clinical practice, one needs to assess all
beneficial and harmful effects of using that test [1].
Medical tests may influence the health of patients by
guiding clinical decisions, for instance if test positive
patients are offered treatment. In addition, medical tests
may also influence patients’ health through other me-
chanisms [1-4]. Testing may provide reassurance if pa-
tients feel uncertain about their condition [5,6] or
provoke anxiety in case of bad news or indistinct test
results [7]. By providing information to patients about
their medical condition, tests may also trigger patients
to alter their behavior and lifestyle [8].This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Effects of medical testing on patients outcomes.
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quences of medical tests, it is important to know how
testing affects patients [1,9]. A clear understanding of
the effects of medical tests on patients may help to
optimize the benefits of these tests in clinical practice.
At present, the variety of effects of medical testing on
patients’ health and its mechanisms has not been sys-
tematically documented. Knowledge about all possible
effects of medical tests on patients could be helpful for
physicians to make optimal clinical use of medical tes-
ting in the widest sense of the term. This may include
physical examinations, lab tests, tissue tests, imaging
tests, invasive and non-invasive tests, and screening,
diagnostic and monitoring tests.
This qualitative study explored the spectrum of effects
of medical testing on patient outcomes from the gyne-
cologists’ perspective, regardless of the clinical manage-
ment decisions. These effects and their underlying
mechanisms will be captured in a clarifying framework.
Methods
We conducted a series of focus group discussions with
medical practitioners. We involved medical practitioners
rather than patients as they better oversee the function,
impact and range of effects on patients of different me-
dical tests for different medical conditions. The study
was carried out in the field of obstetrics, gynecology,
and reproductive health as this specialty covers a wide
range of medical problems for a wide variety of patients.
Sample
MD-PhD candidates working at gynecology departments,
gynecological residents and house officers, and gynecolo-
gists working in peripheral or university hospitals were
invited by personalized emails (purposive sampling by
which we tried to obtain a wide variety of perspectives)
[10]. The physicians signed up at their earliest conve-
nience. Each focus group consisted of three to six physi-
cians from the same hospital with similar functions. New
focus groups were formed until enough data were avail-
able to answer the research question (data saturation).
Since this study did only involve participation of phy-
sicians, not patients, our ethics committee (Medisch
Ethische Toetsingscommissie AMC, Amsterdam, The
Netherlands) did not require written informed consent.
Nine focus groups were conducted in three different
hospitals with in total 14 gynecologists, 19 residents
(age 28–38) and 10 gynecological MD PhD students. All
gynaecologists were 38 years or older with at least 10
years of clinical experience in gynecology, eight worked
in an academic hospital at the time of the focus groups.
All residents were 26–38 years had one to nine years of
clinical work experience in gynaecology, one third had
only worked peripheral hospitals, one third had onlyworked in university hospitals, and one third had
worked both in peripheral and university hospitals. The
MD-PhD candidates were 31 years or younger and had
less than five years of clinical work experience, half of
them in peripheral hospitals and half of them in univer-
sity hospitals.
Procedure
The focus groups interviews were facilitated by MvZ
(qualitative health researcher and ethicist), BO (clinical
epidemiologist specialized in diagnostic test evaluation) or
JV (medical doctor) in turn. Participants were briefly
introduced to the background and aims of this study and
asked to reflect on the following question: ‘Have you ever
performed medical tests or investigations that may have
influenced the health of your patients, regardless of the
effects of subsequent clinical decisions?’ Medical tests
were defined in the the widest sense of the term, including
screening, prognostic, diagnostic, and monitoring tests by
physical examinations, laboratory tests, tissue tests,
imaging tests, invasive and non-invasive procedures, ques-
tionnaires and function tests. During the group discus-
sions a figure illustrating our hypothesis of additional
patient related effects of medical testing was displayed
[Figure 1]. Group discussions were stimulated in an ex-
ploratory manner without any further prompt. All clinical
examples were shared without being traceable to a specific
person and thus respectful toward the privacy and rights
of all patients. The duration of the focus group meetings
took between 1 to 1.5 hours.
Analysis
All focus groups were audio recorded and transcribed ver-
batim. For the purpose of this exploratory study, satu-
ration of data was reached after nine focus groups, as no
new information was gained in the last two focus groups.
Sequential analyses according to the grounded theory
method – a method by which new theories are generated
from systematic data collection – were performed by
MvZ, BO and JV to reduce individual biases [11]. Consen-
sus about the analyses was reached through discussion
amongst the whole research team.
After four focus groups, the transcripts of the focus
group discussions were summarized and coded inductively,
by giving each piece of (potential) relevant information a
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codes were grouped into broad concepts. These were
discussed with an expert panel consisting of senior epide-
miologists and a gynecologist (other authors). In this
expert meeting we decided not to put emphasis on the
medical consequences of the accuracy of a test (including
false negative of false positive results), but to focus on the
consequences of test information in general.
After six focus groups, JV, BO and MvZ independently
performed a second interim analysis. Through successive
data mapping and discussions, a preliminary coding
frame of recurrent themes and concepts was constructed
in consensus amongst the whole research team. We de-
cided to use the input-throughput-output framework
for further analysis, as this model fitted the different
themes. Subsequently, MAXQDA2, a software program
for qualitative data analysis, was used for systematic
organization and storage of the data.
Data from all subsequent focus groups were coded
deductively (with prespecified codes) according to the
updated code tree. Recurrent themes were checked for
group to group validation (a theme had to be recognized
by at least two focus groups) and contradictive data were
sought. New themes were sought and definitions were
accentuated. During this iterative process, we structured
all themes and concepts from the data in a conceptual
framework, reflecting the mechanisms of effects of me-
dical testing on patients.
Results
All participants put forward a variety of clinical examples
from their own practice that illustrated effects of medical
testing on patients. The effects reported throughout the
different focus groups were comparable. Most clinical
examples consisted of three main elements. The first elem-
ent describes factors within the particular context of a test
situation that are essential for the course of such effects.
The second element describes how testing or disclosing
the test results can influence patients’ perception of their
health or clinical situation. The final element encompasses
subsequent effects on patient outcomes. For example, if
testing changes patients’ health perceptions, this may in
turn influence their emotional state and/or behavior.
“Patients presenting with abdominal pain, they often
have all kind of ideas about cancer or severe infection
[contextual factors]. If you perform some tests, and you
can tell them that the ultrasound looks good (…) Then
the people are often reassured and think that it’s
probably just some general intestinal pain, and that their
abdomen will be ok again [perception]. Yes, I often see
that some quick tests can reassure patients and that it
decreases the severity of their complaints [patients’
outcomes].” [Focus group 6]We arranged these three main elements using the
framework of an input-throughput-output model. In this
framework, the contextual factors are considered to be
the necessary input for the development of effects of
medical testing on patients. The subsequent changes in
patients’ perception are considered to be the throughput
that leads to these effects. The output of the model con-
sists of the effects on patients of medical testing them-
selves. This structure reflects the basic outline of the
conceptual framework. The themes derived from the
data could be fitted within this frame.
In the next paragraphs, we shall describe these themes
in more detail, and then present the populated concep-
tual framework. We will thereby report a selection of
factors within each theme, for illustration, rather than
for being all-inclusive.
A. Input: contextual factors
In the clinical examples, different contextual factors were
described that could provoke or contribute to effects of
testing on patients. Notably, the development of these
effects did not only seem to depend on the medical test
and the test result. It was also said to be influenced by the
prior knowledge and beliefs of patients about their health
and the characteristics of the clinical encounter.
A-1. Prior beliefs
Effects of testing on patients were often seen to depend
on the prior (health) beliefs of an individual patient. For
instance, it was mentioned that persons with different
personalities or anxiety levels may experience different
effects of testing, even though they receive the same test
result. Different assumptions about the cause of the
symptoms, especially in patients with different medical
histories, were often said to be an important factor
[Table 1, citation 1]. Cultural differences and medical
traditions were also frequently mentioned. For example,
if patients are used to periodic check-ups, like a yearly
cervical smear, they might feel uncomfortable without
such annual reassurance [citation 2].
A-2. Medical test
Some effects of medical tests on patients were reported
to be a consequence of the test characteristics or the test
results. Physicians were often concerned about false
positive test results, which can induce unnecessary
anxiety in healthy patients, and also inconclusive results
that can neither confirm nor reject a certain condition
and provoke anxiety [citation 3]. Overall participants
thought that imaging tests more frequently generated
effects on patients as compared to non-imaging tests, in
both positive and negative ways. As imaging tests show
patients a visual image of their body, it was said that these
tests results can be more illustrative and convincing to
Table 1 A selection of citations from the focus group
meetings
Input: contextual factors
1 “It is a completely different story if a woman had a previous
stillbirth or if the woman is happily pregnant and seeing a
midwife.” (FG 1)
2 “If we have frightened patients, like DES-daughters with increased
risk for clear cell carcinoma, it is hard to convince them that they
are not at risk anymore at a certain age.” (FG 3)
3 “You have the risk of false positive test results (…) you know that
causes anxiety.” (FG 3)
4 “An image is much more illustrative for patients. (…) it is nicer for
patients to see it themselves directly than to interpret a lab result,
how would they know what a normal result is?” (FG 4)
5 “You can say either ‘I don’t see anything wrong’ or you can say
‘everything looks absolutely marvelous’. It is all subjective; it
depends on how you wrap the message.” (FG 2)
6 “That woman goes through a rough time, and I am not willing
to talk about it for 30 minutes each week. But she will be able to
talk to a nurse during a CTG (…) and she will be happy about
the good results.” (FG 1)
Throughput: perception
7 “If a patients feels fatigued but the hemoglobin is normal, it
illustrates that there must be another cause for their fatigue than
anemia.” (FG 7).
8 “This woman received palliative treatment for metastasized
ovarian cancer. But she used tumor markers as a measurement
of her health, irrespectively of whether she felt healthy or sick.”
(FG 3).
9 “By giving a diagnosis, you show patients that they are not to
blame for developing the illness.” (FG 4)
10 “I think many patients want a label for their disease, to help
them feel in control again. (…) that can really help a patient.”
(FG 5).
11 “I do the test to convince the patient that her vaginal discharge is
normal, she wouldn’t accept it as being normal without a test
(…) then she wouldn’t have felt taken seriously.” (FG 9)
12 “The chance that a patient will go to a different hospital
increases if we withhold from any medical test.” (FG 1)
Output: patient outcomes
13 “A test that can give much reassurance is the cervical length
measurement. (…) Patients attach a large amount of importance
to that result, so if you give them the length measurement and it
is large enough, they are okay again for a while.” (FG 8)
14 “I have a patient who is finally diagnosed with endometriosis. This
diagnosis alone can give a bit of peace and helps to cope with the
complaints, because now the patient knows what causes the
complaints for a fact, and that gives her comfort.” (FG 7)
15 “You have to be careful in performing tests for reassurance, this
can undermine patients’ confidence that things will turn out all
right by themselves. Then they might need a reassuring test for
every little symptom!” (FG 5)
16 “A glucose control can be very confronting for a woman with
diabetes; they might skip the next piece of cake.” (FG 6)
17 “Even if you find no impairment caused by smoking, it might still
kill her if she continues. But her smoking behavior can be
strengthened by the test, because she might reason that the test
result shows that she is immune for the negative effects of
smoking.” (FG 7)
Table 1 A selection of citations from the focus group
meetings (Continued)
18 “For example, if a woman has anemia, but she dislikes iron
tablets, then you can order a hemoglobin test to motivate her to
continue the tablets. You can say that her hemoglobin value has
improved, but has not yet recovered…” (FG 4)
19 “If you can reassure people about certain things, some people
perceive less pain or have fewer complaints. It is a sort of
homeopathic principle.” (FG 3)
20 “Even a normal cyst can make people ill (…) they will develop
abdominal pain immediately.” (FG 7)
FG = focus group.
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tioned for their unintended incidental findings, which
may be spurious but can cause major anxiety in
patients.
A-3. Clinical encounter
We found a profound role for the clinical encounter in
generating effects of testing on patients. The way of
communicating medical information and the test result
was said to be important. Emphasizing favorable results
both verbally and nonverbally was thought to contribute
substantially to patient effects [citation 5]. Alternatively,
tests were sometimes used instrumentally, as part of the
clinical encounter. By performing a test, the physicians
could give medical attention to patients to enhance their
satisfaction about the clinical encounter [citation 6].
B. Throughput: perception
In almost all clinical examples testing had altered pa-
tients’ perceptions of their health. We found three recur-
rent mechanisms by which testing could affect health
perceptions in patients. The most frequently mentioned
mechanisms were a change in patients’ appraisal of their
medical situation and in patients’ perceived control over
their situation. Testing was also said to the influence of
testing on the doctor-patient relationship.
B-1. Appraisal of illness
An important function of testing was seen in improving
patients’ understanding of their disorder. Tests were said
to contribute to patients’ comprehension of their medical
condition or the cause of their complaints. This effect was
described either when the presence of disease was
reflected or if absence of disease was shown [citation 7]. It
was noticed that a test result was often perceived by
patients as an objective sign of their complaints or health
status, even if it reflected subclinical changes [citation 8].
More general, knowledge about their condition was
thought to help patients in better understanding and
anticipating on the likely course of their disease.
Vis et al. BMC Medical Informatics and Decision Making 2013, 13:117 Page 5 of 7
http://www.biomedcentral.com/1472-6947/13/117B-2. Perceived control
Another mechanism by which testing was seen to affect
patient outcomes was by influencing the perceived level of
control patients felt they had over their health. This was
noticed, for instance, that patients sometimes felt guilty or
troubled in situations where they experienced unexplained
symptoms or complaints. Diagnosing an acknowledged
disease was seen to help ease their guilt [citation 9]. It was
also said that most patients with unexplained complaints
were searching for a defined label for their symptoms, to
have something to go by [citation 10]. Tests were also
used for increasing adherence, by showing that patients
can have some control over their disease. For instance,
tests that evaluate an intervention may illustrate patients
that adherence to a certain treatment or lifestyle is effec-
tive for them.
B-3. Doctor - patient relationship
Many participants used medical testing to convince pa-
tients of the value of the proposed management strategy,
especially if patients did not initially trust their health care
providers’ opinion. For example, as some patients did bet-
ter trust a diagnosis if it is grounded on objective parame-
ters, physicians were not always able to convince patients
that an extra medical test would not be beneficial [citation
11]. Physicians also reported that denying a patient a
medical test may make patient feel that they are not taken
seriously and that they are getting sub-standard health-
care. This was seen as having the potential to lower
patients’ adherence to medical advice [citation 12]. Study
participants also said that more extensive counselling
could not always replace the comforting effects of a me-
dical test. Testing was sometimes necessary to maintain
patient satisfaction and the perceived quality of care.
C. Output: patient outcomes
Several effects of medical testing on patient outcomes
were recognized in the clinical examples. We distin-
guished three main categories: psychological outcomes,
behavioral outcomes and medical outcomes.
C-1. Psychological outcomes
It was reported that the testing procedure itself could
influence the emotional state of patients, regardless of the
test result. For instance, testing and waiting for results
could be stressful for patients, this could lead to anxiety.
Yet, more often, reassuring effects of tests were mentioned
[citation 13]. Providing patients with a clear diagnosis was
also believed to have positive effects on patients, as they
may be more willing to accept their medical situation and
get recognition for their complaints [citation 14]. On the
other hand, some patients were said to develop a depen-
dence on reassuring test results to keep a healthy feeling.
In such cases, patients could get very concerned abouttheir health without repeated instrumental reassurance
[citation 15]. This negative effect was reported for a wide
range of screening, diagnostic and prognostic tests.
C-2. Behavioral outcomes
It was also reported that medical testing can affect pa-
tients’ behavior. Physicians sometimes ordered tests to
confront patients with the necessity to change their
behavior [citation 16]. It was questioned whether such
confronting tests would always have beneficial effects
on the behavior of patients, as good test results might
reinforce unfavorable behavior [citation 17]. Additio-
nally, focus group participants emphasized patients’
outcomes in terms of adherence. Improving patients’
understanding of their condition and reinforcing the
doctor-patient relationship through testing was said to
stimulate adherence. Alternatively, it was reported that
evaluating the therapeutic effects could encourage pa-
tients to continue with their therapy [citation 18].
C-3. Medical outcomes
Participants mentioned that psychological effects of tes-
ting may also influence medical outcomes. It was said
that reassurance by negative tests results may lead to a
reduction in complaints [citation 19]. Receiving a posi-
tive test result was sometimes seen to increase the level
of complaints, as this was thought to foster patients’ per-
ceived illness [citation 20]. In addition, examples illus-
trated that effects of testing on adherence and lifestyle
behavior may affect the course of the disease.
D. Conceptual framework
Throughout the clinical examples it became apparent that
different contextual factors around medical testing (input)
could trigger changes in patients’ perception (throughput),
which in turn could result in additional effects on health
outcomes (output). Based on our qualitative data analysis
and synthesis, we arranged the mechanisms and outcomes
in an overall model that reflects the effects of medical tes-
ting on patients. This conceptual framework is sum-
marized in Figure 2. As our analyses were qualitative and
descriptive, we have outlined general patterns of mecha-
nisms and effects of testing on patients, without defining
all specific relationships between different factors.
Discussion
This study evaluated whether and how medical testing
can influence patients’ health through other mechanisms
than clinical management. Our results confirmed that
health care professionals recognize the presence of a wide
range of potential effects of testing on patients, which
operates through several mechanisms. These effects of
testing may favorably or unfavorably affect patient out-
comes in clinical practice. For instance, it was reported
Figure 2 Conceptual framework of effect of medical testing on patients.
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from a negative test result from a feared outcome or, in
case of a positive test result, having a medical explanation
for symptoms even when there is no significant manage-
ment change. Our study demonstrated the importance of
individual circumstances and the clinical encounter in the
appraisal of medical tests [5,12].
To our knowledge, this is the first study to systematic-
ally explore effects of medical testing on patients from a
clinicians’ perspective. Many mechanisms for generating
these effects of testing on patients have been previously
described in adjacent disciplines, such as health psycho-
logy and behavioral medicine. For example, the effects of
testing on anxiety and reassurance of patients are widely
acknowledged [3,6,13]. The influence of health beliefs
and the doctor-patient relationship on medical adhe-
rence has also previously been examined [14]. Yet, a sys-
tematic assessment of such additional effects of testing
on patients is usually not addressed or considered in
medical evaluations of medical tests [15,16]. We suggest
that these effects are incorporated in future test evalua-
tions if these effects are considered to be relevant for
patients, though it remains a challenge to measure and
weigh the value of these effects against more traditional
outcomes.
In some focus groups, the reasons for ordering tests
were also discussed. Many physicians acknowledged that
they regularly ordered tests with the intention to pro-
voke an effect on their patients. Tests were sometimes
ordered to stimulate adherence, to elicit reassurance, or
in response to patients’ preferences in order to maintain
a good physician-patient relationship [17]. We observed
that physicians’ reported primary reasons for ordering a
test were not always in line with the effects of that test.
For example, whereas physicians may focus on detecting
fetal abnormalities to give couples an opportunity to
abort the pregnancy in case of malformations, future
parents often only want to be reassured and informedabout the gender. Yet, several focus groups pointed out
that an increased usage of medical tests might also cause
dependence of these tests for achieving reassurance and
a healthy feeling. An increased availability of medical
tests could increase the future demand for such tests.
Although outside the primary focus of our study,
focus group discussions addressed non-health related
consequences of tests as well, such as financial planning
(concerning mortgage, insurance and career develop-
ment) and consequences for relatives or family plan-
ning. We did not include these other consequences in
our analyses, as we restricted our focus to health-related
effects on patients, although such consequences are in-
creasingly assessed in studies evaluating different forms
of genetic testing [18-20].
A limitation of this study is that the results are only
based on discussions with health care providers in
obstetrics, gynecology and reproductive health. It reflects
their perspective on the role and effects of testing on
patients, mostly females. Although this medical specialty
encompasses a broad spectrum of care, including onco-
logy, elective, acute, chronic, outpatient and inpatient
care, further research is needed to confirm that our re-
sults also apply to other medical areas. It is also possible
that some effects medical tests differ between genders.
In addition, social and cultural context of patients and
physicians may affect the occurrence or magnitude of
these effects. Different types of test (e.g. invasive versus
non-invasive, histology versus biomarker etc.) could also
elicit different effects. Unfortunately, our data provides
insufficient information to further explore this item as
we did not intend to distinguish effects between diffe-
rent types of medical tests throughout the focus groups.
Whether the range of effects of medical testing would
be similar when reported by patients themselves is cur-
rently being investigated.
It remains a challenge to define how the effects identi-
fied in this study can be more systematically addressed
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decision-makers have to be aware that testing can gene-
rate beneficial or harmful effects on patients regardless of
subsequent clinical decision making. Researchers need to
recognize the relevance of such effects in specific testing
situations. For this purpose, it could be useful to develop a
tool that assists in identifying effects of medical testing on
patients. Subsequently, health researchers will need instru-
ments to quantitatively measure and summarize the
effects. Researchers and decision-makers have to work
together in developing ways for incorporating these effects
in comprehensive test evaluations and for weighing them
against more conventional clinical outcomes. In the end,
more comprehensive test evaluations that incorporate the
full range of effects of testing on patients will lead to bet-
ter decisions about testing and, consequently, to a more
effective and efficient health care system.
Conclusion
Testing may affect the perceptions of patients depending
on their prior beliefs, the properties of the medical test,
and the clinical encounter. This may change patients’
perception of the appraisal of their illness, perceived
control, or doctor patient relationship. This may in turn
influence patients’ health through psychological out-
comes, behavioral outcomes, or medical outcomes. We
suggest that both clinicians and health researchers take
these potential additional effects of medical testing on
patients into account within their test recommendations.
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